Making Long-Acting Injectables Work In Clinical Practice – Strategic & Operational Considerations: A Discussion With Greg Ganse, Chief Executive Officer Of Altruix
Greg Ganse, Chief Executive Officer, Altruix, & Monica E. Oss, Chief Executive Officer, OPEN MINDS, discuss the strategic and operational considerations for implementing long-acting injectables (LAIs) in behavioral health settings, and what it takes to turn clinical intent into scalable action.
In this session, Greg Ganse, CEO of Altruix, joins OPEN MINDS CEO Monica Oss to explore the infrastructure, workflows, and staffing strategies behavioral health organizations need to successfully deliver long-acting injectables.
Together, Greg and Monica explore how provider organizations can overcome operational barriers, staffing shortages, and administrative hurdles to expand access to LAIs.
Featured Speaker
Greg Ganse
Chief Executive Officer, Altruix
Greg Ganse is Chief Executive Officer of Altruix, a specialty pharmacy network serving behavioral health, substance use disorder, and I/DD organizations. With over 20 years of experience in the pharmacy field — including leadership roles at Teva and Covidien, and the founding of Ganse Apothecary — Greg now leads Altruix, focusing on the strategic vision for growth. Under his leadership, Altruix has become a key partner to provider organizations looking to improve access, reduce administrative burden, and build sustainable LAI programs.
Altruix is a national specialty pharmacy network focused on improving medication access and management for individuals with behavioral health conditions, substance use disorders, and intellectual and developmental disabilities. Altruix collaborates with provider organizations to support clinical workflows, coordinate prior authorizations, and administer long-acting injectables on-site. Their mission is to remove barriers to care and improve outcomes for underserved populations.
Key Discussion Topics Include:
- How to build and operationalize LAI workflows that improve access, reduce delays, and support long-term sustainability
- Best practices for leveraging alternative staffing models to deliver LAIs despite workforce shortages
- How to partner with specialty pharmacies to streamline coordination, improve efficiency, and reduce burden on care teams
- Strategies for navigating administrative complexity — from prior authorizations to payer requirements
Why It Matters:
Long-acting injectables can reduce relapse, support medication adherence, and improve patient outcomes in behavioral health — but only if organizations can deliver them consistently. This conversation explores how leaders can translate intent into action through strong infrastructure, staffing models, and partnerships that make LAI delivery sustainable at scale.
Want to Read more?
To view this content, please sign up or log in to your account.
Create an account in seconds or log in if you’re already a member.
Sign Up
Sign In
